melanoma patients
Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo
... that melanoma is highly immune dependent malignant ...that melanoma is related to immunosuppression [8] point that this disease is mainly under the control of host ...immunity. Melanoma is very ...
8
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
... in melanoma patients with stage IV disease ...the patients of this study (Tables 2, 3, ...that patients with high basal sCD73 enzyme activity (> ...with patients with sCD73 enzyme ...
9
Telomere length and survival in primary cutaneous melanoma patients
... including melanoma, emerging reports suggest that short telomeres predict poor survival in patients with different ...cutaneous melanoma patients, we show an association between the ...
9
Analysis of prognostic factors for melanoma patients
... of melanoma in men was diagnosed at late stages and 15 cases ...of melanoma cases in women were diagnosed at early stages (39 cas- es, or ...of melanoma at the time of ...that melanoma is rare ...
10
Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients
... The H&E-stained slides for all research and clinical sam- ples are reviewed by a licensed pathologist for (a) con- firmation of the presence of primary melanoma tumor and (b) marking an area containing ...
8
Differences in survival by race/ethnicity among cutaneous melanoma patients in the United States over a period from 1982 to 2011
... Other patients were older in age (70 years or older), while non-Hispanic Black (NHB) and Hispanic patients were younger (30-39 ...years). Melanoma in NHW patients was mostly located in trunk ...
6
Investigating the Effect of Aging and Time on the Fate and Transport of Lead in Artificially Contaminated Tropical soils
... in melanoma patients as compared to patients without melanoma history in this sample of the Taiwanese population: ...among melanoma patients, whereas previous studies ...
24
Coping with melanoma-related worry: a qualitative study of the experiences and support needs of patients with malignant melanoma
... via melanoma clinics at a specialist cancer centre in England seeing approximately 140 new melanoma patients each ...1. Patients were approached following their routine hospital out patient ...
23
Treatment and Outcomes of Melanoma in Acral Location in Korean Patients
... 40 patients between 2001 and 2006 to obtain pertinent demographic data, tumor data, treatment charac- teristics, and follow-up ...Forty melanoma patients were identified and ...female patients ...
7
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
... metastatic melanoma patients must also be considered as evident by our finding that under- insured patients with Medicaid insurance or no insur- ance had a much higher probability of being treated in ...
11
Serum microRNAs as biomarkers for recurrence in melanoma
... including melanoma patients ...III patients, we cannot speculate about a predictive model that would work across all ...oma patients at high risk for ...
10
High Response Rate to Second Line Combination Antiangiogenic Chemotherapy in Patients with Metastatic Melanoma
... metastatic melanoma, evaluated patients receiving bevacizumab in combina- tion with carboplatin and paclitaxel compared to carboplatin, paclitaxel and placebo as a first line treatment ...
12
Melanoma risk loci as determinants of melanoma recurrence and survival
... non-AJ patients and saw largely comparable significant effects in both ...among patients with nodular melanoma (NM), rs9960018 and rs12913832 were associated with both RFS and ...all melanoma ...
14
MALIGNANT MELANOMA OF THE HEAD AND NECK
... of melanoma patients presenting with localized disease actually harbor occult nodal ...Adjuvant melanoma therapy imparts a survival benefit in 25% to 50% of ...of patients with occult disease ...
12
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches
... eight patients undergoing treatment with interferon and bortezomib and four normal donor ...seven melanoma patients receiving various treatments (surgery, radiation, immunotherapy, and/or targeted ...
11
Suppressing immunotherapy by organ-specific tumor microenvironments: what is in the brain?
... cancer patients is the differential responses to systemic treat- ments where some metastatic lesions may be less or more responsive to therapy compared to lesions located at other anatomical ...metastatic ...
8
The Pattern and Cost of Palliative Surgeries in Patients with Metastatic Melanoma
... of patients with dis- tant metastases have widespread micrometastatic disease and circulating tumor ...in patients where some benefits may be expected [6], such as to reduce tumor burden before the use of ...
6
A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma
... Historically, medicines used for the treatment of meta- static melanoma were largely ineffective. Korn et al. [21] reported a historical 2-year overall survival of 8.1% based on a pooled meta-analyses of 42 ...
9
Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma
... of patients’ mean vitamin D levels with re- spect to baseline characteristics were carried out with the use of the Student’s ...for patients with stage III and IV pancreatic cancer with the use of the Cox ...
6
Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis
... GO terms were found related to the activation of the cell cycle, DNA integrity checkpoints, histone phos- phorylation, DNA damage response, signal transduc- tion by p53 class mediation resulting in cell cycle arrest, ...
14